It is urgently required to develop the molecular agents with high therapeutic efficacy and low
side effects for precise cancer therapy. Herein, an advanced multifunctional prodrug B-BDP …

Abstract Development of the drug with high therapeutic efficacy and low toxicity is crucial to
cancer ablation. In this study, we have demonstrated a red light-responsive prodrug BDP-TK …

Combination treatments are more effective than conventional monotherapy in combating
cancer. Herein, a multifunctional prodrug BDP-L-CPT was rationally engineered and …

Herein, we fabricate a multifunctional molecular prodrug BAC where the chemotherapeutical
agent camptothecin (CPT) is linked with a boron dipyrromethene (BODIPY)-based …

During cancer treatment, chemotherapeutic drugs always result in severe side-effects and
drug resistance. Therefore, combining cheomtherapy with other therapeutic modalities, such …

Although boron-dipyrromethene (BODIPY) dyes have been widely recognized for their
potential use as photosensitizers (PSs) in cancer treatment, the development of heavy-atom …

Drug-free biocompatible nanoparticles with photosensitizers as both diagnostic and therapy
agents represent an emerging approach for imaging-guided photodynamic therapy (PDT) …

The development of enzyme-activatable photosensitizers and their combination with
conventional chemodrugs for antitumor therapy are of great interest. In this work, we …

An unsymmetrical bisferrocenyl silicon (IV) phthalocyanine has been prepared in which the
disulfide and hydrazone linkers can be cleaved by dithiothreitol and acid, respectively. The …

Photodynamic therapy (PDT) has emerged as one of the most up-and-coming non-invasive
therapeutic modalities for cancer therapy in rencent years. However, its therapeutic effect …